Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (205)	5/10/1998 2:02:00 AM
From: ahhaha	Read Replies (1) \| Respond to of 399

I suggest you go back to my posts of early February when I sold out at the top and study what I had to say. Since none of the technically astute assimilated the comments I made since they were bloated by their own pretense to knowledge, likewise you will have to reduce your prejudices to glean the significance of what was argued. There is a quantum leap between what ought to work and what works. That leap's cost must be borne by someone. What ARQL discovers still has to be evaluated and that is an expensive process. Though some of the posters believed this company can generate infinite revenues from magical drug design whose tangible cost is swallowed by collaborators, the collaborators simply don't quite agree and don't wish to underwrite the unlimited costs of such speculation. No doubt they push on for the big find, so where are the great 10 drugs ARQL spun out in the past year? I suggest you review my earnings evaluation since you reject ad hominem my criticism of the science. I'm telling you this because the price downtrend is nothing short of disastrous. From decades of direct experience as a pro and knowing H&Q from the inside out, when the institutions that they got on board start selling, you'll see an avalanche. When I tried to convince all of you that the thesis was not well-founded, I knew that many institutions had been bagged similarly. They're all watching, waiting for the bounce. If it doesn't start soon or a breach of 15 or exogenous forces on the interest rate front occur, this stock will quantum tunnel through 5-brane complex space and re-appear at 8. If only there had been panic selling above the stock might have been able to hold the low teens. Now, the price has been whittled to a point where the roaring bulls won't care if the company discovers Harmon's gold; they'll sell through the tunnel. The long term price of this company keeps shrinking and shrinking and shrinking. I just keep wondering when you are going to catch on.